TEST BANK for Clayton's Basic Pharmacology for Nurses 18th Edition by Michelle J. Willihnganz |ISBN: 9780323550611| ultimate guide with guaranteed pass

Clayton's Basic Pharmacology for Nurses 18th
Edition by Michelle J. Willihnganz Test Bank newest
edition

T fh




18THEDITION
fh

,Y Chapter 1: Drug Definitions, Standards, and Information Sources Test Bank
fh fh fh fh fh fh fh fh fh




MULTIPLE CHOICE fh




1. What is the name under which a drug is listed by the U.S. Food and Drug Administration
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



(FDA)?
fh



a. Brand
b. Nonproprietary
c. Official
d. Trademark

ANS: C fh



The official name is the name under which a drug is listed by the FDA. The brand name, or
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



trademark, is the name given to a drug by its manufacturer. The nonproprietary, or
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



generic, name is provided by the U.S. Adopted Names Council.
fh fh fh fh fh fh fh fh fh fh




DIF: Cognitive Level: Knowledge REF: p. 1 OBJ: 2 fh fh f h fh fh



TOP: Nursing Process Step: Assessment
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
f h fh fh fh fh fh fh fh




2. Which source contains information specific to nutritional supplements?
fh fh fh fh fh fh fh



a. USP Dictionary of USAN & International Drug Names
fh fh fh fh fh fh fh



b. Natural Medicines Comprehensive Database fh fh fh



c. United States Pharmacopoeia/National Formulary (USP NF)
fh fh fh fh fh



d. Drug Interaction Facts fh fh




ANS: C fh



United States Pharmacopoeia/National Formulary contains information specific to nutritional
fh fh fh fh fh fh fh fh



supplements. USP Dictionary of USAN & International Drug Names is a compilation of drug
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



names, pronunciation guide, and possible future FDA approved drugs; it does not include
fh fh fh fh fh fh fh fh fh fh fh fh fh



nutritional supplements. Natural Medicines Comprehensive Database contains evidence based
fh fh fh fh fh fh fh fh fh



information on herbal medicines and herbal combination products; it does not include
fh fh fh fh fh fh fh fh fh fh fh fh



information specific to nutritional supplements. Drug Interaction Facts contains
fh fh fh fh fh fh fh fh fh



comprehensive information on drug interaction facts; it does not include nutritional
fh fh fh fh fh fh fh fh fh fh fh



supplements.
fh




DIF: Cognitive Level: Knowledge REF: p. 2 fh fh f h fh OBJ: 4 fh



TOP: Nursing Process Step: Assessment
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Physiological Integrity
f h fh fh fh fh fh




3. What is the most comprehensive reference available to research a drug interaction?
fh fh fh fh fh fh fh fh fh fh fh



a. Drug Facts and Comparisons fh fh fh



b. Drug Interaction Facts fh fh



c. Handbook on Injectable Drugs fh fh fh



d. Martindale—The Complete Drug Reference fh fh fh




ANS: B fh

, First published in 1983, Drug Interaction Facts is the most comprehensive book available on
fh fh fh fh fh fh fh fh fh fh fh fh fh



drug interactions. In addition to monographs listing various aspects of drug interactions, this
fh fh fh fh fh fh fh fh fh fh fh fh fh



information is reviewed and updated by an internationally renowned group of physicians and
fh fh fh fh fh fh fh fh fh fh fh fh fh



pharmacists with clinical and scientific expertise.
fh fh fh fh fh fh




DIF: Cognitive Level: Comprehension REF: p. 3 fh fh f h fh OBJ: 3 fh



TOP: Nursing Process Step: Assessment
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Physiological Integrity
f h fh fh fh fh fh




4. The physician has written an order for a drug with which the nurse is unfamiliar. Which
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



section of the Physicians’ Desk Reference (PDR) is most helpful to get information about
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



this drug?
fh fh



a. Manufacturer‟s section fh



b. Brand and Generic Name section fh fh fh fh



c. Product Category section fh fh



d. Product Information section fh fh




ANS: B fh



A physician‟s order would include the brand and/or generic name of the drug. The alphabetic
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



index in the PDR would make this section the most user friendly. Based on a physician‟s
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



order, manufacturer‟s information and classification information would not be known. The
fh fh fh fh fh fh fh fh fh fh fh



Manufacturer‟s section is a roster of manufacturers. The Product Category section lists
fh fh fh fh fh fh fh fh fh fh fh fh



products subdivided by therapeutic classes, such as analgesics, laxatives, oxytocics, and
fh fh fh fh fh fh fh fh fh fh fh



antibiotics. The Product Information section contains reprints of the package inserts for the
fh fh fh fh fh fh fh fh fh fh fh fh fh



major products of manufacturers.
fh fh fh fh




DIF: Cognitive Level: Comprehension REF: p. 3 fh fh f h fh OBJ: 4 fh



TOP: Nursing Process Step: Planning
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Physiological Integrity
f h fh fh fh fh fh




5. Which online drug reference makes available to health care providers and the public a
fh fh fh fh fh fh fh fh fh fh fh fh fh



fh standard, comprehensive, up to date look up and downloadable resource about medicines?
fh fh fh fh fh fh fh fh fh fh fh



a. American Drug Index fh fh



b. American Hospital Formulary fh fh



c. DailyMed
d. Physicians’ Desk Reference (PDR) fh fh fh




ANS: C fh



DailyMed makes available to health care providers and the public a standard, comprehensive,
fh fh fh fh fh fh fh fh fh fh fh fh



up to date look up and downloadable resource about medicines. The American Drug Index is
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



not appropriate for patient use. The American Hospital Formulary is not appropriate for
fh fh fh fh fh fh fh fh fh fh fh fh fh



patient use. The PDR is not appropriate for patient use.
fh fh fh fh fh fh fh fh fh fh




DIF: Cognitive Level: Knowledge REF: p. 4 fh fh f h fh OBJ: 5 fh



TOP: Nursing Process Step: Implementation
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Physiological Integrity
f h fh fh fh fh fh




6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



a. Federal Food, Drug, and Cosmetic Act (1938) fh fh fh fh fh fh



b. Durham Humphrey Amendment (1952) fh fh fh



c. Controlled Substances Act (1970) fh fh fh

, d. Kefauver Harris Drug Amendment (1962) fh fh fh fh




ANS: A fh



The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



safety of all drugs before marketing. Later amendments and acts helped tighten FDA control
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



and ensure drug safety. The Durham Humphrey Amendment defines the kinds of drugs that
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



cannot be used safely without medical supervision and restricts their sale to prescription by a
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



licensed practitioner. The Controlled Substances Act addresses only controlled substances and
fh fh fh fh fh fh fh fh fh fh fh



their categorization. The Kefauver Harris Drug Amendment ensures drug efficacy and greater
fh fh fh fh fh fh fh fh fh fh fh fh



drug safety. Drug manufacturers are required to prove to the FDA the effectiveness of their
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



products before marketing them.
fh fh fh fh




DIF: Cognitive Level: Knowledge REF: p. 4 fh fh f h fh OBJ: 8 fh



TOP: Nursing Process Step: Assessment
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Physiological Integrity
f h fh fh fh fh fh




7. Meperidine (Demerol) is a narcotic with a high potential for physical and psychological
fh fh fh fh fh fh fh fh fh fh fh fh



fh dependency. Under which classification does this drug fall? fh fh fh fh fh fh fh



a. I
b. II
c. III
d. IV
ANS: B fh



Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead to
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



severe psychological and physical dependence. Schedule I drugs have high potential for abuse
fh fh fh fh fh fh fh fh fh fh fh fh fh



and no recognized medical use. Schedule III drugs have some potential for abuse. Use may
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



lead to low to moderate physical dependence or high psychological dependence. Schedule IV
fh fh fh fh fh fh fh fh fh fh fh fh fh



drugs have low potential for abuse. Use may lead to limited physical or psychological
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



dependence.
fh




DIF: Cognitive Level: Comprehension REF: p. 4 | p. 5 OBJ: 7 fh fh f h fh fh fh fh fh



TOP: Nursing Process Step: Assessment
fh f h fh fh fh



MSC: NCLEX Client Needs Category: Safe, Effective Care Environment
f h fh fh fh fh fh fh fh




8. What would the FDA do to expedite drug development and approval for an outbreak of
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



smallpox, for which there is no known treatment?
fh fh fh fh fh fh fh fh



a. List smallpox as a health orphan disease.
fh fh fh fh fh fh



b. Omit the preclinical research phase. fh fh fh fh



c. Extend the clinical research phase. fh fh fh fh



d. Fast track the investigational drug.
fh fh fh fh




ANS: D fh



Once the Investigational New Drug Application has been approved, the drug can receive
fh fh fh fh fh fh fh fh fh fh fh fh



highest priority within the agency, which is called fast tracking. A smallpox outbreak would
fh fh fh fh fh fh fh fh fh fh fh fh fh fh



become a priority concern in the world. Orphan diseases are not researched in a priority
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



manner. Preclinical research is not omitted. Extending any phase of the research would
fh fh fh fh fh fh fh fh fh fh fh fh fh



mean a longer time to develop a vaccine. The FDA must ensure that all phases of the
fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh fh



preclinical and clinical research phase have been completed in a safe manner.
fh fh fh fh fh fh fh fh fh fh fh fh




DIF: Cognitive Level: Knowledge REF: fh fh f h p. 7 fh OBJ: 8 fh



TOP: Nursing Process Step: Assessment
fh f h fh fh fh